Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 17/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 17/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6131676 | 1.00 | ITGB1 (0.46) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL6532917 | 0.86 | ITGB1 (0.49) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL6132149 | 0.86 | ITGB1 (0.49) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL6132148 | 0.86 | ITGB1 (0.49) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL6532346 | 0.83 | ITGB1 (0.41) | ITGB1ITGA4CYP3A4 | |
| SCHEMBL3836302 | 0.78 | ITGB1 (0.51) | ITGB1ITGA4 | |
| SCHEMBL3833236 | 0.77 | ITGB1 (0.41) | ITGB1ITGA4 | |
| SCHEMBL6131707 | 0.76 | ITGB1 (0.51) | ITGB1ITGA4 | |
| SCHEMBL3834929 | 0.76 | ITGB1 (0.51) | ITGB1ITGA4 | |
| SCHEMBL3830919 | 0.76 | ITGB1 (0.51) | ITGB1ITGA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6951943-B2 | Process for the preparation of phenylalanine enamide derivatives | CELLTECH R & D LIMITED (GB) | 2005-10-04 | — | — | US | disclosed |
| US-20040073033-A1 | Process for the preparation of phenylalanine enamide derivatives | UCB PHARMA S.A. (BE) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073033-A1 | Process for the preparation of phenylalanine enamide derivatives | NPY2R, NPY1R, NPR1 | ITGB1 4148/4885ITGA4 3960/4885CYP3A4 179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.